[PSTX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
07-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 24.51%
YoY- 28.00%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 71,748 25,973 28,142 24,995 9,352 20,013 10,343 262.44%
PBT 20,278 -31,371 -24,274 -25,349 -31,671 -27,456 -38,847 -
Tax 43 0 1,337 -6,040 -107 4,681 1,359 -89.93%
NP 20,235 -31,371 -24,274 -23,990 -31,778 -27,456 -40,206 -
Tax Rate -0.21% - - - - - - -
Total Cost 51,513 57,344 52,416 48,985 41,130 47,469 50,549 1.26%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 28.20 -120.78 -86.26 -95.98 -339.80 -137.19 -388.73 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS 0.21 -0.32 -0.25 -0.27 -0.35 -0.32 -0.47 -
EPS Diluted 0.21 -0.32 -0.25 -0.27 -0.35 -0.32 -0.47 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.